Literature DB >> 21692913

Very early electrodiagnostic findings in Guillain-Barré syndrome.

Maria A Albertí1, Agustí Alentorn, Sergio Martínez-Yelamos, Juan A Martínez-Matos, Monica Povedano, Jordi Montero, Carlos Casasnovas.   

Abstract

Electrodiagnostic studies play a key role in the evaluation of patients with Guillain-Barré syndrome (GBS). However, at early stages patients may not meet current neurophysiologic criteria. We report electrodiagnostic findings for 18 patients with suspected GBS within 4 days of clinical onset. Fifteen patients (83%) showed abnormality in the motor nerve conduction study. Prolonged distal motor latency (DML) was the most frequent demyelinating parameter (seen in 55% of patients). Abnormal late responses were noted in 14 patients (77%). Electrodiagnostic study of cranial nerves was abnormal in eight (44%), and motor nerve conduction velocity was abnormal in only six patients (23%). The study shows a predominant motor neuropathy pattern followed by a sural-sparing pattern; no patients showed a strictly normal electrodiagnostic study. Reduced distal compound muscle action potential and prolonged DML in the demyelinating range were associated with severity of GBS on admission. After the electrodiagnostic study, 5 patients (27%) already fulfilled electrodiagnostic criteria for acute inflammatory demyelinating polyneuropathy (AIDP), 1 (5%) for the axonal variant of GBS, and 13 (72%) were classified as equivocal. We conclude that exhaustive electrodiagnostic studies of patients with suspected GBS in very early stages are useful in the diagnosis and management of the condition.
© 2011 Peripheral Nerve Society.

Entities:  

Mesh:

Year:  2011        PMID: 21692913     DOI: 10.1111/j.1529-8027.2011.00338.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  7 in total

1.  Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics.

Authors:  Angelika Derksen; Christian Ritter; Parveen Athar; Bernd C Kieseier; Pedro Mancias; Hans-Peter Hartung; Kazim A Sheikh; Helmar C Lehmann
Journal:  Muscle Nerve       Date:  2014-09-24       Impact factor: 3.217

2.  Nodopathies in the Early Diagnosis of Axonal Forms of Guillain-Barré Syndrome.

Authors:  Sara Urdiales-Sánchez; José-Ramiro González-Montaña; Ricardo Diaz-Pérez; Pablo Calvo-Calleja; María-Antonia Gutiérrez-Trueba; Javier Urdiales-Urdiales
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

3.  Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability.

Authors:  María J Sedano; Ana Canga; Carmen de Pablos; José M Polo; José Berciano
Journal:  J Neurol       Date:  2013-01-31       Impact factor: 4.849

Review 4.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

5.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

6.  Early Electrodiagnostic Features of Upper Extremity Sensory Nerves Can Differentiate Axonal Guillain-Barré Syndrome from Acute Inflammatory Demyelinating Polyneuropathy.

Authors:  Yong Seo Koo; Ha Young Shin; Jong Kuk Kim; Tai Seung Nam; Kyong Jin Shin; Jong Seok Bae; Bum Chun Suh; Jeeyoung Oh; Byeol A Yoon; Byung Jo Kim
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

7.  Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Authors:  José Berciano; Pedro Orizaola; Elena Gallardo; Ana L Pelayo-Negro; Pascual Sánchez-Juan; Jon Infante; María J Sedano
Journal:  Clin Neurophysiol Pract       Date:  2019-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.